availability has been significantly curtailed - No branded pharmaceutical product exists **Semaglutide:** - FDA-approved for weight management (Wegovy, 2.4 mg weekly) - FDA-approved for type 2 diabetes (Ozempic, up to 2.0 mg weekly) - Available through licensed pharmacies worldwide - Also available through 503B compounding pharmacies as a **weight loss peptide injection** - [View semaglutide products](/products/semaglutide-001) ### Injection Protocol Comparison **AOD-9604 typical research protocol:** - Dose: 250-300 mcg per injection - Frequency: Daily subcutaneous injection (fasting, typically morning) - Cycle length: 12-20 weeks - Total injections per month: ~30 **Semaglutide weight loss injection protocol:** - Starting dose: 0.25 mg weekly (4-week titration steps) - Maintenance dose: 2.4 mg weekly - Frequency: Once weekly subcutaneous injection - Total injections per month: 4 The convenience advantage is substantial
By accessing this content, you acknowledge and agree to use the information responsibly, with the expectation that it will support legitimate research and academic investigation only
From the station, you can take a 5-minute taxi, Uber, or local Bee-Line bus directly to our clinic on North Street
A primary contraindication for Semaglutide / Cyanocobalamin Injection is a known hypersensitivity or allergic reaction to semaglutide, cyanocobalamin, or any of the excipients used in the formulation
Spectacular company and products
These reactions include permanent scarring, skin deformities, cysts, severe infections, etc (1)
